Bill Cosby takes $6 million New York City home off the market
Actor Bill Cosby has again removed his New York City townhouse from the market—weeks after canceling a deposition in an ongoing $60 million rape case because…
Block slashed 40% of its workforce for AI — and its earnings suggest that’s paying off
“We can ship higherquality products much, much more quickly,” an executive said in the wake of the company’s betterthanexpected earnings report…
Sandisk’s stock falls as the company’s forecast doesn’t live up to high expectations
The midpoint of the company’s revenue forecast was below what analysts had been modeling. Source：MarketWatch
Aggressive options trading helped drive the S&P 500’s latest rally. What that means for investors.
The S&P 500 has enjoyed an epic rally over the past five days — but the advance may be more mechanical and driven by options positioning, rather than by an…
Figma’s push into AI agents drives an earnings beat
Figma’s AI monetization strategy is showing promise as customers grow their AIcredit consumption on the platform. Source：MarketWatch
How parents can keep saving for retirement during the expensive childcare years
Young families are striving to do better but struggling with costs of living, including expensive childcare. Source：MarketWatch
Changing how Medicare pays for hospice care could save the U.S. $7.6 billion a year — but at what cost to patients?
The hospice industry argues that the current payment system allows for providers to create individual care plans that meet patients’ specific needs.…
Senate vote on the Protect College Sports Act could come this week: What it means for transfers and salary caps
Here’s how the Protect College Sports Act could impact the economics of college sports. Source：MarketWatch
Why AT&T, Verizon and T-Mobile shares are down after SpaceX’s earnings
SpaceX thinks it will be able to build wireless capabilities without massive network investments. Source：MarketWatch
Retail investors are buying the dip on SpaceX’s stock before more shares flood the market
Retail investors were doing what they do best on Wednesday: Buying the dip in SpaceX shares aggressively, even as the company’s stock sank after it released…
SolarEdge’s stock is shedding a quarter of its value as sales woes trump AI progress
The company faces challenges in Europe, which led to a weakerthanexpected revenue forecast. Source：MarketWatch
How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy?
The Danish company developed the most lucrative new drug the world had ever seen. Then America’s Eli Lilly outmaneuvered it and took control of the dietdrug…